RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$66.39M	-
CEO	Shah Gaurav	778.3K	$2.69M	-
COO	Stevens Christopher James	407.2K	$1.41M	-
Other	Wilson Martin	383.8K	$1.33M	-
Other	Schwartz Jonathan David	299.1K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 21, 2025	Wilson Martin85	General Counsel	Sell	3,222	$10.58	$34,088.76	-2.1%	-37.3%	-63.9%
Feb 21, 2025	Militello John72	See Remarks	Sell	2,737	$10.58	$28,957.46	-4.0%	-37.3%	-63.9%
Feb 21, 2025	Shah Gaurav71	CEO	Sell	16,303	$10.58	$172,485.74	-2.1%	-37.3%	-63.9%
Jan 23, 2025	Militello John72	See Remarks	Sell	896	$10.38	$9,300.48	-1.8%	-35.6%	-66.4%
Nov 21, 2024	Shah Gaurav71	CEO	Sell	11,091	$13.05	$144,781.91	-1.5%	-14.6%	-77.1%
Nov 21, 2024	Militello John72	See Remarks	Sell	1,224	$13.05	$15,978.10	-2.4%	-14.6%	-77.1%
Nov 21, 2024	Patel Kinnari69	See Remarks	Sell	4,588	$13.05	$59,891.75	-1.2%	-14.6%	-77.1%
Nov 21, 2024	Wilson Martin85	General Counsel	Sell	1,175	$13.05	$15,338.45	-1.8%	-14.6%	-77.1%
Oct 31, 2024	Militello John72	See Remarks	Sell	917	$16.63	$15,245.13	-1.8%	-37.5%	-77.4%
Oct 31, 2024	White Mark Andrew79	See Remarks	Sell	3,080	$16.63	$51,205.00	-4.3%	-37.5%	-77.4%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC